Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 124 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
1231 9.8 months Advanced NSCLC 4 Chemotherapy
Hospital Germans Trias I Pujol Hospital Spain 10/2002
Treatment Details: Patients: This Phase III study involved 608 patients with advanced (stage IIIB or IV) non-small-cell lung cancer. Patients were divided into two groups. Group A contained 302 patients and
 
1232 9.8 months Advanced NSCLC 5 Chemotherapy
Royal Victoria Hospital Canada 7/2011
Treatment Details: Patients: This phase II study involved advanced non-small-cell lung cancer patients who had not received prior chemotherapy. Patients were divided into two separate treatment groups. Grou
 
1233 9.8 months Advanced hepatocellular carcinoma 5 Biologic therapy
Massachusetts General Hospital United States 6/2009
Treatment Details: Patients: This phase II study involved 34 advanced hepatocellular carcinoma patients with a median age of 64 years; 85% were male. Treatment: Patients were treated with the biologic the
 
1234 9.8 months Metastatic colorectal carcinoma 5 Chemotherapy
Institut de Cancérologie de l'Ouest France 1/2013
Treatment Details: Patients: This phase 3 study involved metastatic colorectal cancer patients, previously treated with bevacizumab and chemotherapy, who were divided into two separate treatment groups. Ther
 
1235 9.8 months Recurrent GBM 5 Immunotherapy
Northwestern University United States 1/2014
Treatment Details: Patients: This phase 2 study involved 41 recurrent glioblastoma patients with a median age of 55 years; 73% were male. Treatment: Patients were treated with surgery and immunotherapy wi
 
1236 9.7 months Advanced NSCLC 5 Biologic therapy
Institut Gustave Roussy France 2/2014
Treatment Details: Patients: This phase 2 study involved previously treated advanced non-small cell lung cancer patients who were divided into two treatment groups. In group A, there were 66 patients with a
 
1237 9.7 months Recurrent GBM 3 Chemotherapy
Radiation
University ‘‘La Sapienza’’ Italy 4/2011
Treatment Details: Patients: This study involved 36 recurrent glioblastoma patients. The median patient age was 56 years and 22 were men. Treatment: Patients were treated with radiation therapy called fr
 
1238 9.7 months Metastatic melanoma 4 Biologic therapy
Mayo Clinic United States 12/2013
Treatment Details: Patients: This phase 2 study involved 29 patients with metastatic melanoma overexpressing the FGF-2 protein. The median patient age was 64 years and 69% were male. Treatment: Patients
 
1239 9.7 months Metastatic melanoma 5 Chemotherapy
Peter MacCallum Cancer Centre Australia 2/2014
Treatment Details: Patients: This phase 3 study involved metastatic melanoma patients with a mutation in the BRAF gene who had not received prior treatment. Patients were divided into two treatment groups. Gr
 
1240 9.7 months Metastatic urothelial cancer 5 Biologic therapy
Chemotherapy
Fox Chase Cancer Center United States 10/2012
Treatment Details: Patients: This phase 2 study involved pretreated metastatic urothelial cancer patients who were divided into two separate treatment groups. There were 11 patients in group A with a median
 
Page 124 of 187  | Previous Page  | Next Page